By Verity Bell
EDITOR’S SUMMARY: Alzheimer’s, Parkinson’s and ALS are widely assumed to be genetically driven—but genes account for only a minority of cases. Environmental and lifestyle factors play a primary role, operating through overlapping mechanisms: oxidative stress, chronic inflammation, mitochondrial dysfunction and misfolded protein accumulation. The gut microbiome is a surprisingly central player, with disturbances sometimes appearing years before neurological symptoms emerge. Toxic exposures including pesticides, heavy metals, aluminum and microplastics are increasingly implicated—and the dominant amyloid hypothesis in Alzheimer’s research has itself come under scrutiny. Many of these risk factors are modifiable, and earlier intervention may matter more than previously understood.
“You have to die of something!” This off-the-cuff statement is often heard in response to concerns expressed about lifestyle choices. At first glance, it is hard to argue with. But while death is inevitable, not all ways of reaching it are equal. There are certain off-ramps to life’s freeway that most would avoid taking, if given the choice. Not least among those are disorders that affect mobility or the mind, like Alzheimer’s Disease, Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS). All three of these conditions fall under the heading of neurodegenerative disease. Yet they each have a distinctive symptom profile.
The principal impact of Alzheimer’s is the erosion of memory and cognition. Parkinson’s can impair cognition, as well, although it primarily inhibits movement, and ALS (also known as Lou Gehrig’s Disease) progressively paralyzes the voluntary muscles. The experience of developing them has been powerfully portrayed on screen. Alzheimer’s was depicted both by Julianne Moore in Still Alice and Judi Dench in Iris, Parkinson’s by Michael J. Fox in STILL: A Michael J. Fox Movie, and ALS by Frances McDormand in North Country, to name a few.
Perhaps the most terrifying in terms of its rapid and relentless progression, ALS is also, mercifully, the rarest, with approximately 9.1 per 100,000 Americans currently affected. One high-profile example was physicist Stephen Hawking, who lived with the disease for more than 50 years. His case, however, is outstandingly atypical, as the average life expectancy after symptom onset is no more than two to five years. Alzheimer’s and Parkinson’s, on the other hand, though less immediately lethal, are far more prevalent. Alzheimer’s affects a staggering 1 in 9 Americans over 65, and around 1 in 300 is living with Parkinson’s. Moreover, even if the latter two may allow for longer life, the loss of memory, cognition, and physical independence raises difficult questions about the extent to which a prolonged decline is more desirable than a rapid one.
More importantly, all three conditions beg a bigger question: what is at their root, and can you reduce your risk of developing them? Much has been said about the role of genetics in their genesis, but genes account for only a minority of cases. And even where genetic factors are present, it would be more accurate to describe them as increasing your probability of receiving a diagnosis than as determining the matter with fatalistic certainty. Rare exceptions do exist. Certain inherited mutations associated with early-onset Alzheimer’s disease, for instance, as portrayed in the film Still Alice, can make the development of symptoms highly likely. In the overwhelming majority of cases, however, researchers increasingly attribute causation to an interplay between genetic susceptibility and the cumulative impact of biological and environmental stressors.
Establishing a definitive causal connection between environmental factors and the origin of disease is notoriously difficult. After all, it would be neither ethical nor feasible to expose humans to potentially harmful substances in order to observe the long-term outcomes. As a result, scientists must rely on indirect approaches: studying how toxins behave in laboratory models, tracing disease patterns across populations, and examining how specific exposures interact with known biological pathways. Even then, the sheer number of variables—genetics, age, timing of exposure, lifestyle, and chance—makes conclusive proof elusive. Nonetheless, a substantial body of epidemiological and experimental research is beginning to converge upon a striking pattern. Toxic environmental exposures such as pesticides, airborne particulate pollution, industrial solvents, and heavy metals have repeatedly been associated with processes involved in neurodegeneration.
Among the heavy metals of growing interest is aluminum. Researcher Chris Exley, who spent decades studying aluminum biochemistry at Keele University, has documented elevated aluminum concentrations in the brain tissue of Alzheimer’s patients—in some cases at levels he describes as unequivocally high. He and others have proposed that aluminum may promote oxidative stress and protein aggregation, two of the key processes implicated in neurodegeneration. While mainstream science has not reached consensus on aluminum as a causal factor, the accumulating evidence has prompted calls for further investigation. And despite their differing clinical presentations, these same processes have been observed in all three of the aforementioned diseases.
Underlying Mechanisms
One of the biological processes most consistently implicated across these diseases is oxidative stress, a state in which reactive molecules called free radicals accumulate faster than the body’s antioxidant systems can neutralize them. To understand where these molecules come from, it helps to look inside the mitochondria. Here, electrons are passed along a kind of assembly line known as the electron transport chain, in a carefully controlled sequence that enables the cell to produce energy. Factors that drive disruption include diets high in refined carbohydrates, low levels of physical activity, chronic stress, inflammation, and various toxic environmental exposures. Together, these influences interfere with how cells regulate fuel use and contribute to mitochondrial dysfunction.
One key contributor is insulin resistance. Under normal conditions, insulin signals cells to absorb glucose from the bloodstream and use it for energy. But when blood sugar levels remain consistently elevated, cells become less responsive to the cue. Glucose then builds up in the bloodstream as cells struggle to make efficient use of it. This puts a strain on cellular energy systems, compromises mitochondrial function, and increases the likelihood of oxidative stress.
Another major driver of cellular damage is chronic inflammation. Normally, it serves as a protective immune response to injury, toxins, or infection, helping coordinate the body’s defense and repair processes. However, when it becomes persistent—whether due to ongoing stress, environmental exposures, or metabolic imbalance—the signaling molecules that typically support repair start to interfere with cellular regulation. They can blunt the cells’ response to insulin, hinder mitochondrial function, and contribute to oxidative stress and cell damage.
As these changes persist, they begin to affect another critical aspect of cellular health: protein structure maintenance. Proteins must be precisely folded to function properly, and cells rely on quality-control systems to repair or remove misfolded ones. But when oxidative stress and chronic cellular strain overwhelm these systems, protein aggregates accumulate. Over time, their accumulation interferes with cellular activity, ultimately leading to neuron damage and loss.
Environmental toxins are believed to contribute to neurodegeneration precisely because they promote these overlapping processes: oxidative stress, inflammation, mitochondrial dysfunction, and impaired protein maintenance. Which disease develops in a given individual likely depends on which regions of the brain are most at risk. In ALS, genetic variants such as C9orf72 or SOD1 make motor neurons more susceptible to damage, so when stressors accumulate, these are the ones most prone to fail first.
In Alzheimer’s, variants like APOE ε4 can make hippocampal neurons more vulnerable, particularly to protein aggregation (amyloid, tau) and impaired energy metabolism—so when combined with chronic inflammation or metabolic stress, these are the ones most likely to degenerate. In Parkinson’s, the vulnerability resides in the dopaminergic neurons, due to variants like LRRK2 or SNCA. That said, with no known genetic risk, you can still develop one of the conditions if enough cumulative stressors affect vulnerable neurons in a particular area of your brain, while someone with a high-risk gene might never develop disease if biological and environmental stressors are kept to a minimum.
Emerging evidence suggests these stressors—metabolic strain, chronic inflammation, and environmental toxins—interact closely with the gut. The community of microbes that inhabits the digestive tract, known as the microbiome, plays a crucial role in regulating inflammation, supporting the immune system, and maintaining the integrity of the body’s protective barriers. The gut, in fact, functions as a central control hub, influencing the processes that set the stage for brain health or disease. Its lining is designed to allow nutrients to enter the bloodstream while keeping harmful substances out. The beneficial microbes that predominate in a diverse and healthy microbiome help maintain that lining in two important ways.
They support the production of protective mucus and ferment both dietary fiber and resistant starches to produce short-chain fatty acids like butyrate. These not only nourish the gut lining but also help support the brain’s protective barrier. When microbial diversity and beneficial bacteria are lost, the gut lining can weaken, allowing inflammatory molecules—including bacterial fragments called lipopolysaccharides—to enter the bloodstream. The systemic inflammation that follows then compromises the integrity of the blood-brain barrier, increasing oxidative stress in the brain.
Indeed, disturbances in gut function can be like the proverbial canary in the coalmine, appearing as a precursor to neurological symptoms long before their onset. They precede the motor symptoms of Parkinson’s, for example, by many years, and there is evidence to suggest they may be integral to the development of the disease itself. In animal studies, abnormal alpha-synuclein protein introduced into the gut was later detected in the brain, apparently having traveled there along the vagus nerve. In one such study, when the vagus nerve was severed, the spread did not occur.
These findings have contributed to a broader shift in how some researchers think about neurodegenerative disease. Rather than viewing protein deposits such as beta-amyloid, tau, or alpha-synuclein solely as toxic end products, some now suspect they may initially arise as protective responses to infection or as part of the body’s attempt to contain damage. To what degree these accumulations are more a symptom of pathology than a cause of it remains an active area of investigation.
The dominant theory underlying much of Alzheimer’s research—the amyloid hypothesis—has itself come under significant scrutiny. For decades, beta-amyloid plaques were viewed as the primary driver of the disease, directing the lion’s share of research funding and pharmaceutical development toward their removal. Yet drug after drug targeting amyloid has failed to meaningfully alter disease progression. In 2022, a Science investigation raised serious concerns about potential data manipulation in a landmark 2006 paper that had underpinned the hypothesis for nearly two decades. While amyloid almost certainly plays a role in the disease process, the field is now acknowledging that it may be one piece of a far more complex picture—and that researchers who emphasized metabolic dysfunction, neuroinflammation, and environmental factors were perhaps too quickly sidelined.
What You Can Do to Support Your Brain and Gut Health
So, what does all this mean for you? Your gut and your brain are in constant conversation, and you have meaningful influence over both. Start with what you put into your body: invest in a quality water filter and eat a rainbow of organic, fiber-rich foods—fruits, vegetables, nuts, and seeds. These feed the beneficial microbes in your gut and help them produce short-chain fatty acids like butyrate. Incorporate fermented products such as yogurt, kefir, sauerkraut, and kimchi—or raw milk dairy, if accessible and appropriate for you—to introduce additional helpful microbes. Foods rich in antioxidants and anti-inflammatory compounds can likewise protect neurons. For example, polyphenols in sources such as berries, raw honey, and extra-virgin olive oil help combat oxidative stress, while the curcumin in turmeric promotes the growth of new neurons by boosting Brain-Derived Neurotrophic Factor (BDNF).
Resistant starches in cooked and cooled potatoes, beans, and other legumes act as beneficial prebiotics, feeding your gut without spiking blood sugar. Build up fiber gradually, though, and pay attention to how your gut responds. If you’re dealing with conditions like small intestinal bacterial overgrowth (SIBO), certain high-fiber or fermented foods can initially worsen symptoms, and a more targeted approach may be required.
Other valuable additions to your dietary arsenal are sources of omega-3 fatty acids like flaxseed, chia, walnuts, and algae, all of which reduce inflammation and protect neurons from oxidative damage. Equally important for intestinal barrier and microbiome health are essential nutrients such as vitamin D (from sunlight, fatty fish, and eggs), zinc (found in shellfish, grass-fed and finished beef, nuts, and seeds), and vitamin A. Supplements like L-glutamine may also help maintain your gut lining, while recent research has explored the potential neuroprotective effects of the trace mineral lithium. Movement is another indispensable ally. Regular physical activity fuels your mitochondria and stimulates BDNF. Even a short 10-minute walk a few times a week can make an appreciable difference.
Sleep, too, is vital. During rest, your brain’s glymphatic system clears out the byproducts of daily activity, including damaged proteins. By protecting your sleep schedule and prioritizing restorative rest, you can strengthen both brain and gut health with minimal effort. Finally, pay attention to stress. Chronic stress directly affects blood sugar regulation, inflammation, and mitochondrial function. Approaches that help regulate the stress response—whether through lifestyle practices or, in some cases, targeted supplementation—can have far-reaching effects on brain health.
If you are experiencing health challenges despite implementing all of the above, it may be worth investigating less obvious sources of chronic biological stress. Not all harmful exposures are easy to identify. Hidden mold, lingering pathogens such as persistent viral or bacterial infections (potentially including dental sources), and electromagnetic fields can place constant strain on the systems that regulate inflammation, metabolism, and cellular repair. Microplastics are an emerging concern as well—when possible, store food and beverages in glass rather than plastic, and limit exposure to chemicals in household and personal care products, including artificial fragrances.
Aluminum exposure is also worth minimizing where practical. Common sources include aluminum cookware and foil used with acidic foods, many conventional antiperspirants, and certain antacids. Opting for stainless steel or cast iron cookware, choosing aluminum-free personal care products, and reading labels on over-the-counter medications are simple steps that may reduce cumulative contact over time. When these sources go unnoticed, they can persist for years, steadily contributing to biological changes that damage brain cells.
Grounds for Hope
On an encouraging note, your brain is shaped by how you use it and appears to be able to compensate to some extent for biological damage. A neuroimaging initiative revealed that about 30% of elderly adults had beta-amyloid plaques and tau tangles in their brains without showing any symptoms of dementia. This is explained by the concept of “cognitive reserve,” whereby the more you challenge your brain over a lifetime—through learning, problem-solving, social interaction, or acquiring new skills—the more resilient it becomes. In other words, two people with similar levels of physical brain pathology might experience very different levels of impairment. Keeping your brain active is not only enriching; it may help delay or reduce the impact of age-related cognitive decline.
Even a diagnosis does not have to mean that it’s game over. Mainstream medicine will certainly tell you that neurodegenerative disease is irreversible. But is this position justified in every case? Or could it owe something to the failure of conventional treatments to effectively target the multifactorial underlying causes? There is anecdotal evidence to suggest that, in some cases, symptoms may be amenable to reversal, particularly when addressed sufficiently early. A case in point is Dr. Judy Byrne Benjamin, founder of the Alzheimer’s Survivors Foundation, who walked coast to coast across the U.S. 14 years after being told by a doctor that there was nothing that could be done for her. Featured in an article by Apollo Health, Benjamin, who had lost a mother and four uncles to the disease, attributes her recovery to a protocol developed by neurologist Dr. Dale Bredesen and says she is one of a growing number.
The study, “Reversal of Cognitive Decline: 100 Patients,” gives credence to this idea, as a substantial portion of participants either significantly improved or stabilized in response to the same protocol. This method focuses on addressing multiple potential contributors to cognitive decline simultaneously, including metabolic dysfunction, inflammation, sleep quality, nutrition, stress, toxin exposure, and gut health. And Bredesen’s is not the only non-drug-based protocol of this kind to have produced results. In 2024, a documentary called “The Last Alzheimer’s Patient” profiled several people who experienced substantial gains by participating in a clinical trial exploring the impact of intensive lifestyle interventions on early dementia. Even in ALS, rare instances of symptom reversal have been documented. Dr. Richard Bedlack, a neurologist at Duke, has investigated 89 possible cases, of which he has confirmed 65, including that of Mike McDuff, who recovered his ability to speak and swallow within six months of taking a soy-derived peptide called lunasin.
Another natural intervention that has shown promise in all three diseases—at least in terms of slowing progression—is N-acetyl-cysteine (NAC). This compound is a precursor to glutathione, one of the body’s primary antioxidants, and an augmented form has recently been developed that is considerably more absorbable. Not all damage is reversible, of course, and since dopaminergic neurons have a much more limited capacity for regeneration, Parkinson’s symptom reversal stories tend to be less dramatic. Improvement is still possible, however, and collectively, these developments suggest that the trajectory of disease may be more modifiable than once believed. Realizing that potential, however, requires proactive engagement—and the earlier you address underlying imbalances, the greater your opportunity to influence long-term outcomes.
~
Published on June 18, 2026.
If you’ve found value in this article, please share it!
To support the research and health education of AVFC editorial, please consider making a donation today. Thank you.
